Sirenko Syevda G, Potter James D, Knollmann Björn C
Department of Pharmacology, Georgetown University Medical Center, Washington, DC, USA.
J Physiol. 2006 Aug 15;575(Pt 1):201-13. doi: 10.1113/jphysiol.2006.107557. Epub 2006 Jun 15.
Troponin T (TnT) mutations that cause familial hypertrophic cardiomyopathy (FHC) and sudden cardiac death frequently increase myofilament Ca2+ sensitivity, suggesting that their Ca2+-sensitizing effect contributes importantly to the FHC pathogenesis. To test this hypothesis, we compared transgenic mice expressing the Ca2+-sensitizing TnT-I79N mutant (I79N), which causes a high rate of sudden cardiac death in patients, with mice expressing the more benign TnT-R278C mutant (R278C) that does not affect myofilament Ca2+ sensitivity. Acutely increasing myofilament Ca2+ sensitivity with EMD57033 served as a positive control. Isovolumically contracting hearts were compared over a range of loading conditions (Frank-Starling curve). Consistent with their increased myofilament Ca2+ sensitivity, I79N-Tg hearts demonstrated significantly higher systolic performance at low perfusate [Ca2+] compared with R278C-Tg hearts, which were not statistically different from control hearts expressing either human wild-type TnT or no transgene (CON). Diastolic function was impaired in both FHC mutants (time to 90% relaxation: I79N 48 +/- 1.0 ms, n = 10 or R278C 47 +/- 0.4 ms, n = 7, versus CON 44 +/- 1.0 ms, n = 20, P < 0.05). In the presence of isoproterenol, almost all contractile parameters of R278C hearts became indistinguishable from control hearts, whereas both systolic and diastolic function of I79N hearts significantly worsened (end-diastolic pressure: I79N 20 +/- 4 mmHg versus CON 13 +/- 2 mmHg or R278C 11 +/- 2 mmHg, P < 0.05). The Ca2+ sensitizer EMD57033 produced an even greater contractile dysfunction than the I79N mutation at fast pacing rates. In vivo, maximal exercise tolerance was significantly impaired only in I79N mice. Pretreatment with beta-adrenergic receptor antagonists abolished differences in exercise tolerance. In conclusion, the Ca2+-sensitizing effects of TnT mutations may reduce the responsiveness of mouse hearts to inotropic stimuli.
导致家族性肥厚型心肌病(FHC)和心源性猝死的肌钙蛋白T(TnT)突变常常会增加肌丝对Ca2+的敏感性,这表明其Ca2+致敏作用对FHC的发病机制起着重要作用。为了验证这一假设,我们将表达Ca2+致敏性TnT-I79N突变体(I79N)的转基因小鼠与表达对肌丝Ca2+敏感性无影响的良性TnT-R278C突变体(R278C)的小鼠进行了比较,I79N突变体在患者中会导致较高的心源性猝死发生率。用EMD57033急性增加肌丝Ca2+敏感性作为阳性对照。在一系列负荷条件下(Frank-Starling曲线)对等容收缩的心脏进行比较。与肌丝Ca2+敏感性增加一致,与R278C转基因心脏相比,I79N转基因心脏在低灌注液[Ca2+]时表现出显著更高的收缩性能,R278C转基因心脏与表达人野生型TnT或无转基因的对照心脏(CON)在统计学上无差异。两种FHC突变体的舒张功能均受损(90%舒张时间:I79N为48±1.0毫秒,n = 10;或R278C为47±0.4毫秒,n = 7;而CON为44±1.0毫秒,n = 20,P < 0.05)。在异丙肾上腺素存在的情况下,R278C心脏的几乎所有收缩参数都与对照心脏无差异,而I79N心脏的收缩和舒张功能均显著恶化(舒张末期压力:I79N为20±4 mmHg,而CON为13±2 mmHg或R278C为11±2 mmHg,P < 0.05)。在快速起搏频率下,Ca2+致敏剂EMD57033产生的收缩功能障碍比I79N突变更大。在体内,仅I79N小鼠的最大运动耐力显著受损。用β-肾上腺素能受体拮抗剂预处理可消除运动耐力的差异。总之,TnT突变的Ca2+致敏作用可能会降低小鼠心脏对正性肌力刺激的反应性。